Research Status in Mechanism of Endotoxin Tolerance in Uveitis
Yunli Ling1 , Hong Lu1, 2
1 Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China 2 Department of Ophthalmology, the First Hospital of Lanzhou University, Lanzhou 730000, China
Abstract:Endotoxin tolerance, refers to a series of complex and adaptive adjustment reaction produced by the body given small dose of lipopolysaccharide (LPS) in advance. It is a phenomenon of decreased responsiveness of the body or cells to subsequent stimulation. The pretreatment not only can prevent the LPS from causing excessive inflammation in the body, but also can relieve the symptoms of endotoxin-induced uveitis. Therefore, if we can clarify the mechanism and key control factor of endotoxin tolerance in uveitis, we may find new targets for the treatment in uveitis, which is based on endotoxin tolerance.
凌云莉1 卢弘1,2. 葡萄膜炎内毒素耐受机制的研究现状[J]. 中华眼视光学与视觉科学杂志, 2020, 22(4): 315-320.
Yunli Ling1,Hong Lu1, 2. Research Status in Mechanism of Endotoxin Tolerance in Uveitis. Chinese Journal of Optometry Ophthalmology and Visual science, 2020, 22(4): 315-320. DOI: 10.3760/cma.j.cn115909-20191117-00309
Cavaillon JM, Adib-Conquy M. Bench-to-bedside review: Endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit Care, 2006, 10(5): 233. DOI: 10.1186/cc5055.
Beeson PB. Development of tolerance to typhoid bacterial pyrogen and its abolition by reticulo-endothelial blockade. Proc Soc Exp Biol Med, 1946, 61: 248-250. DOI: 10.3181/00379727- 61-15291p.
[6]
del Fresno C, García-Rio F, Gómez-Pi?a V, et al. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol, 2009, 182(10): 6494-6507. DOI: 10.4049/ jimmunol.0803350.
Liu D, Cao S, Zhou Y, et al. Recent advances in endotoxin tolerance. J Cell Biochem, 2019, 120(1): 56-70. DOI: 10.1002/ jcb.27547.
[9]
Howes EL Jr, Rosenbaum JT. Lipopolysaccharide tolerance inhibits eye inflammation. II. Preliminary studies on the mechanism. Arch Ophthalmol, 1985, 103(2): 261-265. DOI: 10.1001/archopht.1985.01050020113032.
[10]
Bhattacherjee P, Parke A. The reduction of inflammatory responses in lipopolysaccharide-tolerant eyes. Am J Pathol, 1986, 122(2): 268-276.
[11]
Zhang N, Yu S, Liu X, et al. Low Dose of Lipopolysaccharide Pretreatment Preventing Subsequent Endotoxin-Induced Uveitis Is Associated with PI3K/AKT Pathway. J Immunol Res, 2017, 2017: 1273940. DOI: 10.1155/2017/1273940.
[12]
Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine, 2008, 42(2): 145-151. DOI: 10.1016/ j.cyto.2008.01.006.
[13]
Maglione PJ, Simchoni N, Cunningham-Rundles C. Toll-like receptor signaling in primary immune deficiencies. Ann N Y Acad Sci, 2015, 1356:1-21. DOI: 10.1111/nyas.12763.
[14]
Chen W, Hu X, Zhao L, et al. Expression of toll-like receptor 4 in uvea-resident tissuemacrophages during endotoxin-induced uveitis. Mol Vis, 2009, 15: 619-628.
Janssens S, Beyaert R. A universal role for MyD88 in TLR/IL- 1R-mediated signaling. Trends Biochem Sci, 2002, 27(9): 474- 482. DOI: 10.1016/s0968-0004(02)02145-x.
[21]
Hartupee J, Li X, Hamilton T. Interleukin 1alpha-induced NFkappaB activation and chemokine mRNA stabilization diverge at IRAK1. J Biol Chem, 2008, 283(23): 15689-15693. DOI: 10.1074/jbc.M801346200.
[22]
Singer JW, Fleischman A, Al-Fayoumi S, et al. Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy. Oncotarget, 2018, 9(70): 33416-33439. DOI: 10.18632/oncotarget.26058.
[23]
Janssens S, Burns K, Vercammen E, et al. MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB and AP- 1-dependent gene expression. FEBS Lett, 2003, 548(1-3): 103- 107. DOI: 10.1016/s0014-5793(03)00747-6.
[24]
Lye E, Mirtsos C, Suzuki N, et al. The role of interleukin 1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK- 4-mediated signaling. J Biol Chem, 2004, 279(39): 40653- 40658. DOI: 10.1074/jbc.M402666200.
[25]
Medvedev AE, Lentschat A, Wahl LM, et al. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxintolerant cells. J Immunol, 2002, 169(9): 5209-5216. DOI: 10.4049/jimmunol.169.9.5209.
Adib-Conquy M, Cavaillon JM. Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression. J Biol Chem, 2002, 277(31): 27927-27934. DOI: 10.1074/jbc. M200705200.
[28]
van't Veer C, van den Pangaart PS, van Zoelen MA, et al. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J Immunol, 2007, 179(10): 7110-7120. DOI: 10.4049/jimmunol.179.10.7110.
[29]
Seki M, Kohno S, Newstead MW, et al. Critical role of IL- 1 receptor-associated kinase-M in regulating chemokinedependent deleterious inflammation in murine influenza pneumonia. J Immunol, 2010, 184(3): 1410-1418. DOI: 10.4049/jimmunol.0901709.
[30]
Hubbard LL, Moore BB. IRAK-M regulation and function in host defense and immune homeostasis. Infect Dis Rep, 2010, 2(1): 22-29. DOI: 10.4081/idr.2010.e9.
[31]
Shiu J, Czinn SJ, Kobayashi KS, et al. IRAK-M expression limits dendritic cell activation and proinflammatory cytokine production in response to Helicobacter pylori. PLoS One, 2013, 8(6): e66914. DOI: 10.1371/journal.pone.0066914.
[32]
Yu S, Liu X, Zhang N, et al. Protection of Lipopolysaccharide (LPS) Preconditioning against Endotoxin-Induced Uveitis (EIU) in Rats is Associated with Overexpression of Interleukin-1 Receptor-Associated Kinase M (IRAK-M). Ocul Immunol Inflamm, 2018, 26(6): 943-950. DOI: 10.1080/09273948.2017.1291842.
[33]
Moore KW, de Waal Malefyt R, Coffman RL, et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol, 2001, 19: 683-765. DOI: 10.1146/annurev. immunol.19.1.683.
Frankenberger M, Pechumer H, Ziegler-Heitbrock HW. Interleukin-10 is upregulated in LPS tolerance. J Inflamm, 1995, 45(1): 56-63.
[36]
Dong GH, Gong JP, Li JZ, et al. Association between gene polymorphisms of IRAK-M and the susceptibility of sepsis. Inflammation, 2013, 36(5): 1087-1093. DOI: 10.1007/s10753- 013-9641-z.
[37]
Xu Y, Chen W, Lu H, et al. The expression of cytokines in the aqueous humor and serum during endotoxin-induced uveitis in C3H/HeN mice. Mol Vis, 2010, 16(182): 1689-1695.
[38]
Mashimo H, Ohguro N, Nomura S, et al. Neutrophil chemotaxis and local expression of interleukin-10 in the tolerance of endotoxin-induced uveitis. Invest Ophthalmol Vis Sci, 2008, 49(12): 5450-5457. DOI: 10.1167/iovs.08-1878.
[39]
Davtyan TK, Mkrtchyan NR, Manukyan HM, et al. Dexamethasone, colchicine and iodine-lithium-alphadextrin act differentially on the oxidative burst and endotoxin tolerance induction in vitro in patients with Beh?et's disease. Int Immunopharmacol, 2006, 6(3): 396-407. DOI: 10.1016/ j.intimp.2005.09.003.
[40]
Lennikov A, Kitaichi N, Noda K, et al. Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats. Mol Vis, 2012, 18: 2586-2597.
[41]
Lennikov A, Kitaichi N, Noda K, et al. Amelioration of endotoxin-induced uveitis treated with the sea urchin pigment echinochrome in rats. Mol Vis, 2014, 20: 171-177.
[42]
Keles S, Halici Z, Atmaca HT, et al. The ocular endothelin system: a novel target for the treatment of endotoxin-induced uveitis with bosentan. Invest Ophthalmol Vis Sci, 2014, 55(6):3517-3524. DOI: 10.1167/iovs.14-14193.
Qin X, Jiang X, Jiang X, et al. Micheliolide inhibits LPSinduced inflammatory response and protects mice from LPS challenge. Sci Rep, 2016, 6: 23240. DOI: 10.1038/srep23240.
[45]
Xu H, Su Z, Wu J, et al. The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4/phosphatidylinositol 3-kinase gamma pathway. J Immunol, 2010, 184(3): 1492-1498. DOI: 10.4049/ jimmunol.0902660.
[46]
Deladeriere A, Gambardella L, Pan D, et al. The regulatory subunits of PI3Kγ control distinct neutrophil responses. Sci Signal, 2015, 8(360): ra8. DOI: 10.1126/scisignal.2005564.
[47]
Ho PC, Tsui YC, Feng X, et al. NF-κB-mediated degradation of the coactivator RIP140 regulates inflammatory responses and contributes to endotoxin tolerance. Nat Immunol, 2012, 13(4): 379-386. DOI: 10.1038/ni.2238.
Pockar S, Globocnik Petrovic M, Peterlin B, et al. MiRNA as biomarker for uveitis-A systematic review of the literature. Gene, 2019, 696: 162-175. DOI: 10.1016/j.gene.2019.02.004.
[50]
Yang L, Du L, Yue Y, et al. miRNA Copy Number Variants Confer Susceptibility to Acute Anterior Uveitis With or Without Ankylosing Spondylitis. Invest Ophthalmol Vis Sci, 2017, 58(4): 1991-2001. DOI: 10.1167/iovs.16-21047.
[51]
Hsu YR, Chang SW, Lin YC, et al. MicroRNA-146a Alleviates Experimental Autoimmune Anterior Uveitis in the Eyes of Lewis Rats. Mediators Inflamm, 2017, 2017: 9601349. DOI: 10.1155/2017/9601349.
[52]
Muhammad F, Trivett A, Wang D, et al. Tissue-specific production of MicroRNA-155 inhibits melanocortin 5 receptordependent suppressor macrophages to promote experimental autoimmune uveitis. Eur J Immunol, 2019, 49(11): 2074-2082. DOI: 10.1002/eji.201848073.
[53]
O'Rourke M, Trenkmann M, Connolly M, et al. Novel gene targets for miRNA146a and miRNA155 in anterior uveitis. Br J Ophthalmol, 2019, 103(2): 279-285. DOI: 10.1136/ bjophthalmol-2018-312885.
[54]
Essandoh K, Fan GC. Role of extracellular and intracellular microRNAs in sepsis. Biochim Biophys Acta, 2014, 1842(11): 2155-2162. DOI: 10.1016/j.bbadis.2014.07.021.
[55]
Quinn EM, Wang J, Redmond HP. The emerging role of microRNA in regulation of endotoxin tolerance. J Leukoc Biol, 2012, 91(5): 721-727. DOI: 10.1189/jlb.1111571.
[56]
Gao M, Wang X, Zhang X, et al. Attenuation of Cardiac Dysfunction in Polymicrobial Sepsis by MicroRNA- 146a Is Mediated via Targeting of IRAK1 and TRAF6 Expression. J Immunol, 2015, 195(2): 672-682. DOI: 10.4049/ jimmunol.1403155.
[57]
Vergadi E, Vaporidi K, Tsatsanis C. Regulation of endotoxin tolerance and compensatory anti-inflammatory response syndrome by non-coding RNAs. Front Immunol, 2018, 9: 2705. DOI: 10.3389/fimmu.2018.02705.
[58]
Liu G, Wang Y, Zhang M, et al. Long non-coding RNA THRIL promotes LPS-induced inflammatory injury by down-regulating microRNA-125b in ATDC5 cells. Int Immunopharmacol, 2019, 66: 354-361. DOI: 10.1016/j.intimp.2018.11.038.
[59]
Deng Y, Luan S, Zhang Q, et al. Long noncoding RNA THRIL contributes in lipopolysaccharide-induced HK-2 cells injury by sponging miR-34a. J Cell Biochem, 2019, 120(2): 1444-1456. DOI: 10.1002/jcb.27354.
[60]
Li Z, Chao TC, Chang KY, et al. The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc Natl Acad Sci USA, 2014, 111(3): 1002-1007. DOI: 10.1073/pnas.1313768111.
[61]
Wang Y, Fu X, Yu B, et al. Long non-coding RNA THRIL predicts increased acute respiratory distress syndrome risk and positively correlates with disease severity, inflammation, and mortality in sepsis patients. J Clin Lab Anal, 2019, 33(6): e22882. DOI: 10.1002/jcla.22882.
[62]
Sheng C, Hu F, Wu L. Geniposide alleviates hypoxia-induced injury by down-regulation of lncRNA THRIL in rat cardiomyocytes derived H9c2 cells. Eur J Pharmacol, 2019, 854: 28-38. DOI: 10.1016/j.ejphar.2019.03.058.
[63]
Moharamoghli M, Hassan-Zadeh V, Dolatshahi E, et al. The expression of GAS5, THRIL, and RMRP lncRNAs is increased in T cells of patients with rheumatoid arthritis. Clin Rheumatol, 2019, 38(11): 3073-3080. DOI: 10.1007/s10067-019-04694-z.
[64]
Wang C, Deng L, Hong M, et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature, 2001, 412(6844): 346-351. DOI: 10.1038/35085597.
Walsh MC, Lee J, Choi Y. Tumor necrosis factor receptorassociated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system. Immunol Rev, 2015, 266(1): 72-92. DOI: 10.1111/imr.12302.
[67]
Yang S, Yu S, Liu X, et al. Inhibiting Effect of Lithium Chloride on Endotoxin-induced Uveitis in Rats. Ocul Immunol Inflamm, 2018, 26(5): 798-806. DOI: 10.1080/09273948.2016.1269932.
[68]
Brudecki L, Ferguson DA, McCall CE, et al. Mitogen-activated protein kinase phosphatase 1 disrupts proinflammatory protein synthesis in endotoxin-adapted monocytes. Clin Vaccine Immunol, 2013, 20(9): 1396-1404. DOI: 10.1128/CVI.00264-13.
[69]
Rorato R, Borges BC, Uchoa ET, et al. LPS-induced low-grade inflammation increases hypothalamic JNK expression and causes central insulin resistance irrespective of body weight changes. Int J Mol Sci, 2017, 18(7): 1-14. DOI: 10.3390/ijms18071431.